Quick Answer

Yes, Mounjaro is FDA-approved and safe when prescribed and monitored by a registered pharmacist. Extensive clinical trials support its safety profile. Not suitable for everyone - our pharmacist assesses eligibility during consultation.

Is Mounjaro Safe?

Medical Review: Reviewed by registered pharmacist. Last Updated: December 2025. Location: Glasgow, Scotland.

Mounjaro Safety Overview

Mounjaro (tirzepatide) is an FDA-approved medication for weight loss management. It has undergone extensive clinical trials involving thousands of patients, demonstrating a favourable safety profile when used as prescribed under medical supervision.

At our Glasgow clinic, all Mounjaro prescriptions are provided by a registered pharmacist who assesses your eligibility, monitors your progress, and ensures your safety throughout treatment. Learn more about Mounjaro treatment.

Clinical Trial Safety Data

Mounjaro's safety has been evaluated in multiple clinical trials:

SURMOUNT Trials: Studies involving over 2,500 patients over 72 weeks
Adverse Events: Most side effects were mild to moderate and temporary
Serious Events: Low incidence of serious adverse events
Long-term Data: Ongoing studies continue to monitor long-term safety

Who Should Not Take Mounjaro

Mounjaro is contraindicated for certain individuals:

People with medullary thyroid carcinoma (MTC)
People with multiple endocrine neoplasia syndrome type 2 (MEN 2)
People with severe gastrointestinal disease
Pregnant or breastfeeding women
People with a history of pancreatitis
People with severe kidney or liver disease

Our pharmacist will review your medical history during consultation to determine if Mounjaro is safe for you. See our contraindications guide and eligibility information.

Common Side Effects

Most side effects of Mounjaro are mild to moderate and temporary:

Nausea (most common)
Vomiting
Diarrhoea
Constipation
Abdominal pain
Decreased appetite

These side effects typically occur when starting treatment or increasing dosage, and usually improve over time. Our pharmacist monitors you throughout treatment to manage any side effects. Learn more about Mounjaro side effects.

Safety Monitoring

When you receive Mounjaro treatment through our Glasgow clinic, your safety is our priority:

Initial Assessment: Comprehensive medical review before prescribing
Regular Follow-ups: Ongoing monitoring of your progress and side effects
Dosage Adjustments: Treatment tailored to your individual needs
Access to Support: Direct contact with our pharmacist for any concerns

Comparing Mounjaro Safety to Other Treatments

Mounjaro's safety profile is similar to other GLP-1 medications like Wegovy. Both are FDA-approved and have extensive safety data. Mounjaro may have slightly different side effect profiles due to its dual-action mechanism. Compare: Mounjaro vs Wegovy.

Frequently Asked Questions

Is Mounjaro safe to use?

Yes, Mounjaro is FDA-approved and considered safe when prescribed and monitored by a healthcare professional. It has undergone extensive clinical trials involving thousands of patients.

What are the main safety concerns with Mounjaro?

Mounjaro is contraindicated for people with medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. It should not be used during pregnancy or breastfeeding.

Are there long-term safety studies on Mounjaro?

Yes, Mounjaro has been studied in clinical trials for up to 72 weeks, showing sustained safety and efficacy. Ongoing studies continue to monitor long-term safety.

Who should not take Mounjaro?

Mounjaro is not suitable for people with certain medical conditions including thyroid cancer, severe gastrointestinal disease, or those who are pregnant or breastfeeding. Our pharmacist will assess your suitability during consultation.

How is safety monitored during treatment?

Our registered pharmacist monitors your progress through regular follow-ups, reviews any side effects, and adjusts treatment as needed to ensure your safety throughout the treatment period.